Involvement of the Erk-MAP kinase pathway in TNFα regulation of trabecular matrix metalloproteinases and TIMPs

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 164-169

  Alexander, J Preston ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; RAF PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TRABECULAR MESHWORK; TRABECULOPLASTY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; ENZYME INHIBITORS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SWINE; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASES; TRABECULAR MESHWORK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037247620     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.01-1201     Document Type: Article

References (50)

1. Acott TS. Biochemistry of aqueous humor outflow. In: Kaufman PL, Mittag TW, eds. Textbook of Ophthalmology. Vol. 1. London: Mosby; 1994:1.47-1.78.
2. Acott TS. Trabecular extracellular matrix regulation. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Williams & Wilkins; 1992:125-157.
3. Acott TS, Wirtz MK. Biochemistry of aqueous outflow. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Vol. 1. St. Louis: Mosby; 1996:281-305.
4. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
5. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, eds. Cell Biology of Extracellular Matrix. New York: Plenum; 1991:255-302.
6. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.
7. Woessner J, Nagase H. Matrix Metalloproteinases and TIMPs. Oxford, UK: Oxford University Press; 2000.
8. Parks W, Mecham R, eds. Matrix Metalloproteinases. San Diego: Academic Press; 1998.
9. Bradley JMB, Vranka JA, Colvis CM, et al. Effects of matrix metalloproteinase activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
10. Bradley JMB, Kelley MJ, Zhu XH, Anderssohn AM, Alexander JP, Acott TS. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci 2001;42:1505-1513.
11. Parshley DE, Bradley JMB, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vivo laser treatment to the trabecular meshwork. Curr Eye Res. 1995;14:537-544.
12. Parshley DE, Bradley JMB, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795-804.
13. Bradley JMB, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41:422-430.
14. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
15. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
16. Fini M, Cook J, Mohan R, Brinckerhoff C. Regulation of matrix metalloproteinase gene expression. In: Parks W, Mecham RP, eds. Matrix Metalloproteinases. San Diego: Academic Press; 1998:299-356.
17. Matrisian LM. The matrix-degrading metalloproteinases (Review). Bioessays. 1992;14:455-463.
18. Matrisian LM. Matrix metalloproteinase gene expression (Review). Ann N Y Acad Sci. 1994;732:42-50.
19. Crawford H, Matrisian L. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein. 1996;49:20-37.
20. Kirstein M, Sanz L, Quinones S, Moscat J, Diaz-Meco MT, Saus J. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J Biol Chem. 1996;271:18231-18236.
21. Rutter J, Benbow U, Coon C, Brinckerhoff C. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1β (IL-1β) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem. 1997;66:322-336.
22. Basuyaux J, Ferreira E, Stehelin D, Buttice G. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem. 1997;272:26188-26195.
23. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common Cis element recognized by a TPA-modulated trans-acting factor. Cell. 1987;49:729-739.
24. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci. 1994;732:31-41.
25. Nagase H, Woessner J. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
26. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res. 1998;17:276-285.
27. Bjorkoy G, Overvatn A, Diaz-Meco MT, Moscat J, Johansen T. Evidence for a bifurcation of the mitogenic signaling pathway activated by ras and phosphatidylcholine-hydrolyzing phospholipase C. J Biol Chem. 1995;270:21299-21306.
28. Diaz-Meco MT, Quinones S, Municio MM, et al. Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene and phosphatidylcholine-hydrolyzing phospholipase C. J Biol Chem. 1991;266:22597-22602.
29. Gaire M, Barro CD, Kerr LD, Carlisle F, Matrisian LM. Protein kinase C isotypes required for phorbol-ester induction of stromelysin-1 in rat fibroblasts. Mol Carcinogenesis. 1996;15:124-133.
30. McDonnell SE, Kerr LD, Matrisian LM. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol. 1990;10:4284-4293.
31. Alexander JP, Acott TS. Involvement of protein kinase C in TNFα regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2001;42:2831-2838.
32. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129-157.
33. McCawley L, Li S, Wattenberg E, Hudson L. Sustained activation of the mitogen-activated protein kinase pathway. J Biol Chem. 1999;274:4347-4353.
34. Brogley M, Cruz M, Cheung H. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal-transduction pathway. J Cell Physiol. 1999;180:215-224.
35. Korzus E, Nagase H, Rydell R, Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem. 1997;272:1188-1196.
36. Shearer T, Crosson C. Activation of extracellular signal-regulated kinase in trabecular meshwork cells. Exp Eye Res. 2001;73:25-35.
37. Polansky JR, Weinreb R, Alvarado JA. Studies on human trabecular cells propagated in vitro. Vision Res. 1981;21:155-160.
38. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
39. Harlow E, Lane D. Antibodies: A laboratory Manual. Cold Spring Harbor, NY: Cold Springs Harbor Laboratory; 1988.
40. Alexander JP, Bradley JMB, Gabourel JD, Acott TS. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990;31:2520-2528.
41. Pang L, Sawada T, Decker S, Saltiel A. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.
42. Kyriakis J, App H, Zhang X-f, et al. Raf-1 activates MAP kinasekinase. Nature. 1992;358:417-421.
43. Force T, Bonventre J, Heidecker G, Rapp U, Avruch J, Kyriakis J. Enzymatic characteristics of the c-Raf-1 protein kinase. Proc Natl Acad Sci USA. 1994;91:1270-1274.
44. Poulos J, Weber J, Bellezzo J, et al. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat stellate cells. Am J Physiol. 1997;273:G804-G811.
45. Genersch E, Haye K, Neuenfeld Y, Haller H. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci. 2000;113:4319-4330.
46. Laird A, Morrison D, Shalloway D. Characterization of Raf-1 activation in mitosis. J Biol Chem. 1999;274:4430-4439.
47. Leevers S, Paterson H, Marshall C. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 1994;369:411-414.
48. Waters S, Holt K, Ross S, et al. Desensitization of Ras activation by a feedback dissociation of SOS-Grb2 complex. J Biol Chem. 1995;270:20883-20886.
49. Pang I-H, Shade D, Clark A. Involvement of activation protein-1 (AP-1) in interleukin-1α (IL-1α)-induced stimulation of stromelysin (MMP-3) expression in cultured human trabecular meshwork (TM) cells [ARVO Abstract]. Invest Ophthalmol Vis Sci 2000;41:S503. Abstract nr 2680.
50. Morrison D, Kaplan D, Rapp U, Roberts T. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA. 1988;85:8855-8859.